Dana Blankenhorn

Dana Blankenhorn

InvestorPlace Contributor

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

Ford Stock Isn’t Quite at the End of Its Road, But It Won’t Run Forever

By Dana Blankenhorn, InvestorPlace Contributor

Ford is well-positioned in the electric vehicle race. But Electric cars don't have to be repaired and replaced like gas-powered vehicles.

Lucid Stock Makes Tesla Look Cheap

By Dana Blankenhorn, InvestorPlace Contributor

LCID stock has a ridiculously high valuation, especially given that the future of transportation could be very different.

Speculate With Rocket Lab as It Grows Through Acquisitions

By Dana Blankenhorn, InvestorPlace Contributor

RKLB stock is from a small company with a big valuation. It's using funds to buy other companies and become a larger space supplier.

Nvidia: Metaverse Turns its Hype Factor to 11

By Dana Blankenhorn, InvestorPlace Contributor

Nvidia is building an entire software stack for the metaverse, from chips to computers to application interfaces, hoping to take full advantage of the new buzzword.

With Progenity, What Is Pumped Will Be Dumped

By Dana Blankenhorn, InvestorPlace Contributor

Progenity came public as a genetic testing company in 2020, then closed the lab and is doing early-stage clinical trials.

Carnival Shares Have Not Left the Dock

By Dana Blankenhorn, InvestorPlace Contributor

Carnival has been dancing with debt since the pandemic began and had $28 billion of it in August. In its best years it had revenue of $20 billion.

Merck Is a Dividend Play Ready to Get Back in Gear

By Dana Blankenhorn, InvestorPlace Contributor

Pfizer has been beating MRK stock in 2021, but that relative performance may reverse next year, with new drugs and acquisitions ahead.

Being First Is Not Enough For Crispr Therapeutics

By Dana Blankenhorn, InvestorPlace Contributor

CRSP stock is facing competition and meeting skepticism as the company tries to turn CRISPR-CAS9 into profitable drug therapies.

IBM: The Curse of Value

By Dana Blankenhorn, InvestorPlace Contributor

While the tech industry has gone to glory over the last five years, IBM stock is down 22%, and it's not coming back

With Affirm, All They Want Is Growth

By Dana Blankenhorn, InvestorPlace Contributor

Affirm's deals with Amazon, Shopify and Target have made it the clear leader in the Buy Now, Pay Later space, but the rest of the consumer credit industry is now after it.

Load More